Silent IL2RG Gene Editing in Human Pluripotent Stem Cells

Area of Science:

• Stem cell biology
• Gene editing
• Chromatin regulation

Background:

• Pluripotent stem cells (PSCs) are crucial for regenerative medicine.
• Editing silent chromosomal genes in PSCs is challenging due to marker gene silencing.
• Efficient gene editing in PSCs is essential for therapeutic applications.

Purpose of the Study:

• To overcome limitations in isolating edited PSC clones.
• To develop a method for efficient editing of silent chromosomal genes in PSCs.
• To investigate the role of IL2RG in immune cell differentiation from PSCs.

Main Methods:

• Utilized a ubiquitous chromatin opening element (UCOE) promoter-driven transgene to enhance selectable marker expression.
• Employed a recombinant adeno-associated virus (rAAV)-targeting vector for homologous recombination.
• Edited the silent IL2RG locus in human PSCs without site-specific nucleases.
• Analyzed histone modifications and cytosine methylation patterns.

Main Results:

• The UCOE promoter strategy successfully overcame selectable marker silencing in edited PSC clones.
• IL2RG was confirmed to be essential for natural killer and T-cell differentiation from human PSCs.
• Insertion of the UCOE promoter transiently altered local chromatin structure, which resolved upon removal.

Conclusions:

• The UCOE promoter-driven transgene strategy provides an efficient method for editing silent genes in PSCs.
• This approach facilitates the correction of genetic defects, such as IL2RG mutations in X-linked severe combined immunodeficiency.
• The method holds potential for regenerative medicine, including preventing graft-versus-host disease and editing other silent genes.